K024116

Substantially Equivalent

WIENER LAB. BILIRUBINA DIRECT AA

Applicant: Wiener Laboratories Saic
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 2002-12-13
Decision date: 2003-02-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Rosario, Santa Fe, AR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.